<DOC>
	<DOCNO>NCT01973101</DOCNO>
	<brief_summary>The purpose phase II study determine survival free disease patient diagnose invasive locally advanced carcinoma uterine cervix treat induction chemotherapy cisplatin gemcitabine follow chemoradiation definitive chemoradiation .</brief_summary>
	<brief_title>Non-comparative Study Treatment With Induction Chemotherapy With Cisplatin Gemcitabine Followed Chemoradiation Definitive Chemoradiation Invasive Locally Advanced Carcinomas Uterine Cervix .</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>1 . Advanced carcinoma uterine cervix histological confirm . 2 . Indication definitive chemoradiation treatment ; 3 . Measurable disease RECIST 1.1 ( Response Evaluation Criteria Solid Tumors ) criteria ; 4 . Age 18 year old 70 year old ; 5 . Adequate bone marrow organ function define laboratory value ; 6 . Non evidence disease paraaortic lymph node ; 1 . Previous treatment Chemotherapy radiotherapy 2 . Previous surgery primary tumor ; 3 . Distant metastasis ; 4 . Performance status accord Eastern Cooperative Oncology Group great 2 ; 5 . Peripheric neuropathy great grade 2 National Cancer Institute Common Toxicity Criteria Adverse Events ( NCICTCAE ) version 3.0 ; 6 . Significant Cardiac disease ( history and/or active disease ) ; 7 . Other treatment cancer , include hormonotherapy ; 8 . Psychiatric addictive disorder condition , opinion investigator , would preclude patient meeting study requirement ;</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Advanced carcinoma uterine cervix</keyword>
	<keyword>Chemoradiation</keyword>
	<keyword>Chemo-induction</keyword>
	<keyword>Cisplatin</keyword>
	<keyword>Gemcitabine</keyword>
</DOC>